The results revealed that IGF2BP3 high-expression is positively correlated with the JAK/STAT signaling pathway; notably, GSEA was conducted to investigate the possible mechanism by which IGF2BP3 participates in the occurrence and progression of AML (Fig. 6A). This evidence concerns the gene SOAT1 and acute myeloid leukemia.